ENDRA Life Sciences (NDRA) Current Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Current Assets for 11 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 201.53% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 201.53% increase from a year earlier, with the FY2025 full-year figure at $967969.0, down 71.81% from the prior year.
• Current Assets was $5.6 million for Q2 2026 at ENDRA Life Sciences, up from $536666.0 in the prior quarter.
• Over five years, Current Assets peaked at $14.5 million in Q2 2022 and troughed at $536666.0 in Q1 2026.
• A 5-year average of $5.2 million and a median of $5.2 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 78.87% in 2025 and surged 201.53% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $5.4 million in 2022, then plunged by 43.62% to $3.0 million in 2023, then advanced by 13.22% to $3.4 million in 2024, then tumbled by 71.81% to $967969.0 in 2025, then jumped by 477.19% to $5.6 million in 2026.
• The last three Current Assets figures came in at $5.6 million (Q2 2026), $536666.0 (Q1 2026), and $967969.0 (Q4 2025), per Business Quant data.